By Counterforce Health Team in Poteligeo (mogamulizumab-kpkc) —

Do You Qualify for Poteligeo Coverage by UnitedHealthcare in Georgia? Decision Tree & Next Steps

Answer Box: UnitedHealthcare requires prior authorization for Poteligeo (mogamulizumab-kpkc) for relapsed/refractory mycosis fungoides or Sézary syndrome after ≥1 prior systemic therapy. Submit via UHC Provider Portal with staging documentation, prior therapy records, and medical necessity letter from oncologist/dermatologist. If denied, appeal within 180 days or request Georgia external review within 60 days of final denial. Start today: gather pathology report, TNMB staging, and prior therapy dates/outcomes.

Table of Contents

  1. How to Use This Guide
  2. Eligibility Triage
  3. If "Likely Eligible" - Documentation Checklist
  4. If "Possibly Eligible" - Tests to Request
  5. If "Not Yet" - Alternative Options
  6. If Denied - Appeal Path Chooser
  7. Georgia External Review Process
  8. Coverage at a Glance
  9. Common Denial Reasons & Fixes
  10. FAQ

How to Use This Guide

This decision tree helps patients and clinicians navigate UnitedHealthcare's prior authorization (PA) requirements for Poteligeo (mogamulizumab-kpkc) in Georgia. Work through each section sequentially to determine your eligibility status and next steps.

Start here: Do you have a confirmed diagnosis of mycosis fungoides (ICD-10 C84.0) or Sézary syndrome (ICD-10 C84.1) with pathology report?

  • ✅ Yes → Continue to Eligibility Triage
  • ❌ No → Request biopsy/pathology review first

Eligibility Triage

Answer these questions to determine your coverage likelihood:

1. Diagnosis Confirmed?

  • Required: Pathology-confirmed mycosis fungoides or Sézary syndrome
  • Stage: IB-IV via TNMB/ISCL-EORTC criteria (topical/radiation-only cases may face extra scrutiny)

2. Prior Systemic Therapy?

UnitedHealthcare requires ≥1 failed/inadequate systemic therapy. Qualifying therapies include:

  • Extracorporeal photopheresis (ECP)
  • Interferon-α
  • Oral bexarotene
  • Methotrexate
  • HDAC inhibitors (vorinostat, romidepsin)
  • Brentuximab vedotin (if CD30+)
  • Conventional chemotherapy

Note: Topical therapies alone (steroids, mechlorethamine) or radiation do NOT satisfy step therapy requirements.

3. Prescriber Qualifications?

  • Required: Oncologist, hematologist, or dermatologist
  • Preferred: Board certification in relevant specialty

4. Recent Labs Available?

  • CBC with differential
  • Comprehensive metabolic panel
  • Within 30-60 days of submission

Your Status:

  • All ✅ → Likely Eligible - proceed to documentation
  • Missing 1-2 items → Possibly Eligible - complete requirements first
  • Missing 3+ items → Not Yet - build foundation before applying

If "Likely Eligible" - Documentation Checklist

Required Documents for PA Submission

Document Type Specific Requirements Where to Obtain
Medical Necessity Letter Patient ID, diagnosis/staging, prior therapies table, rationale vs alternatives, dosing plan Prescribing physician
Pathology Report Confirms MF/SS diagnosis with subtype Hospital/lab records
Staging Documentation TNMB staging within 60 days, disease extent Recent clinic notes
Prior Therapy Records Drug names, dates, doses, responses, discontinuation reasons Medical records
Recent Labs CBC, metabolic panel (≤60 days) Lab results portal
Provider Attestation Physician signature confirming medical necessity Prescriber

Submission Path

  1. Portal: UHC Provider Portal → Prior Authorization tool
  2. Codes: Use HCPCS J9204, NDC 42747-0761-xx
  3. Timeline: Expect decision within 30 days (standard) or 72 hours (expedited)
  4. Confirmation: Record submission number and follow up in 3-5 days
Tip: Upload documents as clearly labeled PDFs with page numbers. Include a cover sheet summarizing key eligibility criteria met.

If "Possibly Eligible" - Tests to Request

Missing Staging Documentation?

  • Request TNMB staging assessment from dermatology/oncology
  • Include skin exam findings, lymph node assessment, blood work
  • Document disease extent and progression

Unclear Prior Therapy History?

  • Compile chronological therapy table:
    • Drug name and dates
    • Maximum dose achieved
    • Best response (complete/partial/stable/progressive)
    • Reason for discontinuation

Need Specialist Referral?

  • Obtain consultation with oncologist, hematologist, or dermatologist
  • Ensure provider is in UnitedHealthcare network
  • Request detailed assessment letter

Timeline to Re-apply: Allow 2-4 weeks to gather missing documentation before PA submission.

If "Not Yet" - Alternative Options

Standard Treatment Sequence

Before Poteligeo approval, consider discussing these evidence-based options with your physician:

For Early-Stage Disease:

  1. Skin-directed therapies (topical steroids, PUVA, narrow-band UVB)
  2. Topical chemotherapy (mechlorethamine gel)
  3. Oral bexarotene or low-dose methotrexate
  4. HDAC inhibitors (vorinostat, romidepsin)

For Sézary Syndrome/Blood Involvement:

  1. Extracorporeal photopheresis ± interferon-α
  2. Systemic bexarotene
  3. Romidepsin or other HDAC inhibitor
  4. Consider duvelisib (NCCN Category 2A after ≥1 prior therapy)

Exception Request Strategy

If standard therapies are contraindicated:

  • Document specific contraindications (e.g., cardiac risk with bexarotene, neuropathy precluding brentuximab)
  • Obtain specialist clearance letters
  • Request medical exception through UHC provider services

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by identifying denial basis and crafting point-by-point rebuttals aligned to each plan's specific rules and requirements.

If Denied - Appeal Path Chooser

Level 1: Internal Appeal (UnitedHealthcare)

  • Deadline: Within 180 days of denial notice
  • Timeline: 30 days for standard, 72 hours for expedited
  • How to File: UHC member portal, phone, or written appeal
  • Required: Enhanced medical necessity documentation addressing specific denial reasons

Level 2: Peer-to-Peer Review

  • When: If Level 1 denied for medical necessity
  • Process: Prescriber speaks directly with UHC medical director
  • Timeline: Usually scheduled within 1-2 weeks
  • Preparation: Review denial letter, gather supporting studies/guidelines

Level 3: External Review (Georgia)

  • Eligibility: After exhausting internal appeals
  • Deadline: Within 60 days of final UHC denial
  • Cost: Free to consumers
  • Process: Independent physician review through Georgia Department of Insurance

Georgia External Review Process

Georgia provides robust external review rights for UnitedHealthcare denials through the Department of Insurance (OCI).

Filing Requirements

  1. Complete internal appeals first (unless urgent/expedited case)
  2. Submit within 60 days of final denial letter
  3. Include required documents:
    • Original denial notice
    • Medical records supporting necessity
    • Physician letter explaining why Poteligeo is medically necessary
    • Prior therapy failure documentation

Process Timeline

  • Standard Review: 30 business days for decision
  • Expedited Review: 72 hours if delay poses serious health risk
  • OCI Processing: 10 working days to assign independent review organization

How to File

  • Contact: Georgia Office of Consumer Services
  • Phone: 1-800-656-2298
  • Online: Submit complaint/inquiry form through OCI website
  • Mail: Include original plus 3 copies of all documents
Important: External review decisions are binding on UnitedHealthcare. If approved, the insurer must cover Poteligeo treatment.

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required Must get approval before treatment UHC formulary or provider portal UHC PA Requirements
Step Therapy ≥1 prior systemic therapy required Medical records, therapy timeline UHC Clinical Criteria
Specialist Required Oncologist/hematologist/dermatologist Provider directory UHC Network
HCPCS Code J9204 for billing CMS fee schedule CMS HCPCS
ICD-10 Codes C84.0 (MF), C84.1 (SS) Pathology report Medical records
Appeal Deadline 180 days from denial Denial notice UHC policy
External Review 60 days from final denial Georgia DOI Georgia OCI

Common Denial Reasons & Fixes

Denial Reason How to Overturn Required Documents
"Step therapy not met" Provide detailed prior therapy table with outcomes Pharmacy records, physician notes, therapy timeline
"Not medically necessary" Enhanced medical necessity letter with guidelines NCCN references, FDA labeling, clinical studies
"Missing staging" Submit current TNMB staging assessment Recent staging workup, imaging reports
"Wrong prescriber type" Transfer to qualified specialist Referral to oncology/hematology/dermatology
"Incomplete documentation" Provide all required attachments Checklist review, missing document submission

FAQ

Q: How long does UnitedHealthcare PA take in Georgia? A: Standard PA decisions typically take up to 30 days. Expedited reviews (for urgent cases) are completed within 72 hours.

Q: What if Poteligeo is non-formulary on my plan? A: Request medical exception with enhanced documentation showing other formulary options failed or are contraindicated.

Q: Can I request expedited appeal if treatment is urgent? A: Yes. If delay could seriously jeopardize your health, request expedited internal appeal (72 hours) and expedited external review in Georgia.

Q: Does step therapy apply if I failed treatments in another state? A: Yes. Prior systemic therapy failures from any location count toward UnitedHealthcare's step therapy requirements.

Q: What counts as "systemic therapy" for step therapy? A: Oral or IV medications that treat the whole body (bexarotene, interferon, methotrexate, HDAC inhibitors, ECP). Topical treatments alone don't qualify.

Q: Can my family member help with appeals? A: Yes, with proper authorization. Complete UnitedHealthcare's authorized representative form to allow family involvement.

Q: What if UnitedHealthcare doesn't respond within deadlines? A: File complaint with Georgia Department of Insurance Consumer Services. Insurers must meet regulatory timelines.

Q: Are there financial assistance programs for Poteligeo? A: Yes. Contact Kyowa Kirin patient support at 1-844-768-3544 for copay assistance and foundation grant information.

This guide is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider for medical decisions. For official appeals guidance, contact the Georgia Department of Insurance Consumer Services at 1-800-656-2298.

When navigating complex insurance denials and appeals, Counterforce Health helps patients, clinicians, and specialty pharmacies get prescription drugs approved by turning denials into targeted, evidence-backed appeals that address each plan's specific coverage criteria and procedural requirements.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.